Similar Papers

Paper Title
Journal
Date
Author
Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate
Wen-Hua Xiao ... Jiang-Yang Lu
Chinese journal of oncology | VOL. 33
Wen-Hua Xiao, et. al.Wen-Hua Xiao ... Jiang-Yang Lu
01 Jun 2011
Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate – The impact of fibrosarcomatous transformation
P Rutkowski ... T Świtaj
European Journal of Surgical Oncology (EJSO) | VOL. 43
P Rutkowski, et. al.P Rutkowski ... T Świtaj
22 Mar 2017
Data from Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Paolo G Casali ... Annalisa Astolfi
-
Paolo G Casali, et. al.Paolo G Casali ... Annalisa Astolfi
31 Mar 2023
Data from Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Alessandro Gronchi ... Valentina Indio
-
Alessandro Gronchi, et. al.Alessandro Gronchi ... Valentina Indio
31 Mar 2023
View more papers

More From: European Journal of Surgical Oncology

Paper Title
Journal
Date
Author
Intraperitoneal Paclitaxel with Systemic S-1 Plus Oxaliplatin for Advanced or Recurrent Gastric Cancer with Peritoneal Metastasis: A single-arm, multicenter phase II clinical trial
Won Jun Seo ... Jong-Han Kim
European Journal of Surgical Oncology | VOL. -
Won Jun Seo, et. al.Won Jun Seo ... Jong-Han Kim
01 Jan 2025
Lymph Node Metastasis Prediction Model for Each Lymph Node Station in Gastric Cancer Patients
Jong Won Kim ... Han-Kwang Yang
European Journal of Surgical Oncology | VOL. -
Jong Won Kim, et. al.Jong Won Kim ... Han-Kwang Yang
01 Jan 2025
OBC: Advert ESSO Hands on Course on Oncological Standards in Minimally Invasive Colorectal Cancer Surgery
-
European Journal of Surgical Oncology | VOL. -
--
01 Jan 2025
Editorial Board
-
European Journal of Surgical Oncology | VOL. -
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.